Narla et al., 1998 - Google Patents
4-(3'-Bromo-4'hydroxylphenyl)-amino-6, 7-dimethoxyquinazoline: a novel quinazoline derivative with potent cytotoxic activity against human glioblastoma cells.Narla et al., 1998
View PDF- Document ID
- 688334716925123760
- Author
- Narla R
- Liu X
- Myers D
- Uckun F
- Publication year
- Publication venue
- Clinical cancer research: an official journal of the American Association for Cancer Research
External Links
Snippet
Abstract The novel quinazoline derivative 4-(3'-bromo-4'-hydroxylphenyl)-amino-6, 7- dimethoxyquinazoline (WHI-P154) exhibited significant cytotoxicity against U373 and U87 human glioblastoma cell lines, causing apoptotic cell death at micromolar concentrations …
- 208000005017 Glioblastoma 0 title abstract description 55
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in positions 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48369—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying part being an antibody, an immunoglobulin, or a fragment thereof, e.g. a Fc-fragment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Narla et al. | 4-(3'-Bromo-4'hydroxylphenyl)-amino-6, 7-dimethoxyquinazoline: a novel quinazoline derivative with potent cytotoxic activity against human glioblastoma cells. | |
US6316454B1 (en) | 6,7-Dimethoxy-4-anilinoquinazolines | |
US5990141A (en) | Treatment of platelet derived growth factor related disorders such as cancers | |
US6331555B1 (en) | Treatment of platelet derived growth factor related disorders such as cancers | |
TWI468397B (en) | Quinazoline derivatives | |
JP5139083B2 (en) | Quinoxaline derivatives as antitumor agents | |
US8735439B2 (en) | Chlorin e6-folic acid conjugate, preparation method thereof, and a pharmaceutical composition for the treatment of cancer comprising the same | |
JP2002540103A (en) | Quinazolines and their therapeutic use | |
You et al. | Pheophorbide-a conjugates with cancer-targeting moieties for targeted photodynamic cancer therapy | |
HU221622B1 (en) | Quinazoline derivatives, pharmaceutical compositions comprising same as active ingredient and process for producing them | |
AU2006201635A1 (en) | Novel inhibitors and methods for their preparation | |
Narla et al. | Inhibition of human glioblastoma cell adhesion and invasion by 4-(4'-hydroxylphenyl)-amino-6, 7-dimethoxyquinazoline (WHI-P131) and 4-(3'-bromo-4'-hydroxylphenyl)-amino-6, 7-dimethoxyquinazoline (WHI-P154). | |
JP2003502412A (en) | Melamine derivatives as potent anticancer agents | |
Narla et al. | hydroxylphenyl)-amino-6, 7-dimethoxyquinazoline: A Novel Quinazoline Derivative with Potent Cytotoxic Activity against Human Glioblastoma Cells | |
Li et al. | SAR-guided development of indole-matrine hybrids as potential anticancer agents via mitochondrial stress/cytochrome c/caspase 3 signaling pathway | |
CN114409636B (en) | Quinazolinone compound or pharmaceutically acceptable salt thereof, and preparation method and application thereof | |
TW201602086A (en) | Arylamine substututed quinoxaline and their use as anticancer drugs | |
JP2002030083A (en) | N-(2-chloro-4-{[6-methoxy-7-(3-pyridylmethoxy)-4- quinolyl]oxy}phenyl)-n'-propylurea dihydrochloride | |
CN111574503A (en) | Pyrimidine double aromatic ring derivative epidermal growth factor inhibitor and preparation method and application thereof | |
Wang et al. | Novel thiohydantoin analogues bearing the 1-hydroxyl-2, 2, 2-trifluoro-1-ethyl moiety as androgen receptor inhibitors for the potential treatment of castration resistant prostate cancer | |
WO2019052046A1 (en) | Quinazolines compound, preparation method therefor and application thereof | |
AU718272B2 (en) | Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth factor receptor | |
WO2001035952A2 (en) | Radiosensitization of human glioblastoma cells by quinazoline compounds | |
MXPA96002680A (en) | Treatment of disorders related to platelet derived growth factor, such commons, using growth receiver inhibitors derived from plate |